UNC Immunotherapy Team, University of North Carolina at Chapel Hill is a clinical research site located in Chapel Hill, North Carolina, United States 27599.
Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.
UNC Immunotherapy Team, University of North Carolina at Chapel Hill has participated in 1 clinical trials.
Therapeutic areas: Relapsed or Refractory Hodgkin Lymphoma, Peripheral T Cell Lymphoma.
Sponsors: Affimed GmbH.
Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
UNC Immunotherapy Team, University of North Carolina at Chapel Hill has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UNC Immunotherapy Team, University of North Carolina at Chapel Hill has 1 clinical trials on record. Their work covers Relapsed or Refractory Hodgkin Lymphoma, Peripheral T Cell Lymphoma.
UNC Immunotherapy Team, University of North Carolina at Chapel Hill has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.